Clinical Trials Directory

Trials / Unknown

UnknownNCT03469622

EndoRings Colonoscopy for Adenoma Detection

EndoRings Versus Standard Colonoscopy for Adenoma Detection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
225 (estimated)
Sponsor
Helios Albert-Schweitzer-Klinik Northeim · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the colonoscope for improving the ADR. This work is the first GERMAN randomized controlled trial comparing standard colonoscopy with EndoRIngs-assisted colonoscopy. EndoRings is a new FDA approved device that is attached to the distal tip of the colonoscope. Better Polyp detection is suspected by flattening the mucosal folds during withdrawal

Conditions

Interventions

TypeNameDescription
DEVICEEndoRingsEndoRings-assisted colonoscopy
DEVICEStandard colonoscopyStandard colonoscopy without any additional devices

Timeline

Start date
2018-03-27
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-03-19
Last updated
2019-02-12

Locations

5 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT03469622. Inclusion in this directory is not an endorsement.